Article info
Clinical science
Three-month outcome of intravitreal ziv-aflibercept in eyes with diabetic macular oedema
- Correspondence to Dr Jay Chhablani, Smt. Kanuri Santhamma Centre for Vitreo Retinal Diseases, LV Prasad Eye Institute, Hyderabad, TS 500034, India; jay.chhablani{at}gmail.com
Citation
Three-month outcome of intravitreal ziv-aflibercept in eyes with diabetic macular oedema
Publication history
- Received March 8, 2016
- Revised April 5, 2016
- Accepted April 26, 2016
- First published May 17, 2016.
Online issue publication
January 20, 2017
Article Versions
- Previous version (17 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/